INTERNATIONAL PATENT: MIRATI THERAPEUTICS, INC. FILES APPLICATION FOR "COMBINATION THERAPIES USING PRMT5 INHIBITORS AND IMMUNE CHECKPOINT INHIBITORS FOR THE TREATMENT OF CANCER"

GENEVA, Oct. 20 -- MIRATI THERAPEUTICS, INC. (Route 206 and Province Line RoadPrinceton, New Jersey 08543) filed a patent application (PCT/US2025/023366) for "COMBINATION THERAPIES USING PRMT5 INHIBITORS AND IMMUNE CHECKPOINT INHIBITORS FOR THE TREATMENT OF CANCER" on Apr 07, 2025. With publication no. WO/2025/217007, the details related to the patent application was published on Oct 16, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): ENGSTROM, Lars Daniel (c/o Bristol-Myers Squibb CompanyRoute 206 and Province Line RoadPrinceton, New Jersey 08543), OLSON, Peter (c/o Bristol-Myers Squibb Com...